Posts By Alex
-
410Wire StoriesEnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
EnginZyme and Ajinomoto Bio-Pharma Services have developed a patented process to manufacture pseudouridine at industrial scale using biocatalysis in a sustainable, low-waste,...
-
333Wire StoriesSogo & Seibu Co., Ltd.: Regarding our company’s executive personnel change
TOKYO–(BUSINESS WIRE)–Sogo & Seibu Co., Ltd. (hereinafter referred to as “Sogo & Seibu”) has decided to appoint Mr. Davide Sesia as Executive...
-
390Wire StoriesEditage Partners with IPB University to Support Researchers with Publication Needs
JAKARTA, Indonesia–(BUSINESS WIRE)–#CactusCommunications—Editage, the flagship brand of Cactus Communications (CACTUS) — a science communication and technology company — has announced a partnership...
-
415Wire StoriesLubrizol’s Apisolex™ Polymer Wins Finished Formulation Award at CPhI Barcelona
Solubility-enhancing Excipient for Injectable Drug Formulations Wins Prestigious CPhI Barcelona Award CLEVELAND–(BUSINESS WIRE)–Lubrizol Life Science Health, a leading pharmaceutical company, has won...
-
423Wire StoriesGigXR Partners with NUS Medicine to Deliver Holographic Clinical Scenarios for Gastroenterology Training
LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–GigXR, Inc., a global provider of holographic healthcare training, announced today its partnership with the Yong Loo Lin...
-
407Wire StoriesHeartland BancCorp Earns $4.9 Million, or $2.43 Per Diluted Share, in the Third Quarter of 2023; Declares Quarterly Cash Dividend of $0.759 per Share
WHITEHALL, Ohio, Oct. 24, 2023 (GLOBE NEWSWIRE) — Heartland BancCorp (“Heartland” and “the Company”) (OTCQX: HLAN), parent company of Heartland Bank (“Bank”),...
-
464Wire StoriesCoupang to Announce Third Quarter 2023 Results on November 7, 2023
SEATTLE–(BUSINESS WIRE)–Coupang, Inc. (NYSE: CPNG) will release its third quarter 2023 financial results on Tuesday, November 7, 2023 (Eastern Time). The release...
-
336Wire StoriesBuyer Consortium Led by Recco Control Technology and Dazheng Group Responds to Hollysys’ Update on Sale Process
Reminds Shareholders of Similar Fact Pattern in 2021 Fully Expects Board to Move Forward with Special Meeting After it Confirmed Receipt of...
-
435Wire StoriesGlycologix Treats First Patient in Pilot Study of GLX-100 for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Multi-center clinical study designed to evaluate safety, tolerability and effectiveness of a novel biopolymer device. BEVERLY, Mass. & MELBOURNE, Australia–(BUSINESS WIRE)–Glycologix, Inc....
-
4.5KFoodWhy drink loose-leaf tea?
Preparing tea can be a ritual to help you develop mindfulness and set the tone for your day. Brewing tea can awaken...
